CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (UNAUDITED)	3 Months Ended
	Mar. 31, 2015 USD ($)	Mar. 31, 2015 CAD	Mar. 31, 2014 USD ($)	Mar. 31, 2014 CAD
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss for the period | $	$ (1,000,304)		$ (1,972)
Adjustments to reconcile net (loss) to net cash (used in) operating activities:
Depreciation and amortization		CAD 3,179
Amortization of deferred financing fees		995
Legal fees incurred deducted from proceeds of notes payable		11,500
Fair value adjustment in derivative liabilities		33,390
Common stock/stock options issued or to be issued for services rendered		771,875
Change in assets and liabilities
(Increase) in prepaid expenses and deposits | $	(101,171)
(Decrease) in accounts payable and accrued expenses | $	(18,017)		$ 902
Total adjustments		701,751		CAD 902
Net cash (used in) operating activities | $	(298,553)		(1,070)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds received from convertible notes		355,000
Repayments of notes payable		CAD (5,000)
Net member contributions				CAD 400
Cash received for common stock and liability for stock to be issued	7,000,000			CAD 0
Net cash provided by financing activities | $	420,000		400
NET INCREASE (DECREASE) IN CASH | $	121,477		(670)
CASH - BEGINNING OF PERIOD | $	13,346		$ 670
CASH - END OF PERIOD	$ 134,793
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid during the period for: Interest		CAD 5,000
Cash paid during the period for: Income taxes
Reverse Merger of Breathe LLC
Accumulated deficit		CAD 7,733,077
Prepaid expenses		191,584
Fixed assets		138,049
Mining rights		1,035,818
Accounts payable		(111,275)
Asset retirement obligations		(107,749)
Note payable		(125,451)
Accumulated comprehensive income		114,446
Due to Company		221,159
Adjustment to APIC		9,089,658
Investment in Tauriga Sciences, Inc. ("TAUG")
Common shares issued for investment in Tauriga		CAD 100,000